Shangdong Dong-E Spins Off Donkey Meat Business
This article was originally published in PharmAsia News
Executive Summary
Shangdong Dong-E E-Jiao Group's foray into the donkey meat business has received orders worth over 40 million yuan since its entry in 2007. Targeting sales of 600 million yuan over the next three years, the firm has invested 120 million yuan to make it China's top brand. The spinoff business arose from Dong-E's bid to secure more donkey-hide gelatin, a pharmaceutical raw material in short supply. In fact, many traditional Chinese medicine enterprises face the same problem of limited supply; experts advise that these companies should consider extending their strategy to upstream raw materials like what Dong-E is doing. (Click here for more - Chinese Language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.